In:
IUPHAR/BPS Guide to Pharmacology CITE, Edinburgh University Library, Vol. 2023, No. 1 ( 2023-04-26)
Abstract:
Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [98]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors [61] .
Type of Medium:
Online Resource
ISSN:
2633-1020
DOI:
10.2218/gtopdb/F61/2023.1
Language:
Unknown
Publisher:
Edinburgh University Library
Publication Date:
2023